Colgate-Palmolive (NYSE:CL) Downgraded by StockNews.com to “Hold”

StockNews.com cut shares of Colgate-Palmolive (NYSE:CL) from a buy rating to a hold rating in a report published on Friday.

Several other brokerages also recently weighed in on CL. JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a research note on Friday. Piper Sandler decreased their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Morgan Stanley decreased their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Finally, Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $101.72.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $89.80 on Friday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock’s 50-day moving average is $89.02 and its two-hundred day moving average is $94.82. The firm has a market cap of $72.87 billion, a P/E ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 EPS. Analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Colgate-Palmolive

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $27,000. Vermillion Wealth Management Inc. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $31,000. Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $32,000. Finally, Briaud Financial Planning Inc acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $32,000. 80.41% of the stock is owned by institutional investors and hedge funds.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.